Complete Filing Data
Instil Bio, Inc. reported Stockholders Equity of $113.87 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Instil Bio, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$71.4M | -$74.1M | -$156.1M | -$223.2M | -$156.8M | -$37.7M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$342.0K | $168.0K | -$433.0K | $9.0K | $246.0K | -$283.0K |
| Operating Income Loss | -$78.6M | -$73.5M | -$159.2M | -$226.5M | -$155.6M | -$33.6M |
| Operating Expenses | $78.6M | $73.5M | $159.2M | $226.5M | $155.6M | $33.8M |
| Nonoperating Income Expense | $212.0K | -$2.9M | -$575.0K | -$564.0K | -$1.3M | -$3.9M |
| General And Administrative Expense | $27.2M | $44.2M | $47.6M | $62.2M | $48.3M | $14.4M |
| Comprehensive Income Net Of Tax | -$71.7M | -$74.0M | -$155.9M | -$223.6M | -$156.6M | -$38.0M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$355.0K | $120.0K | $145.0K | -$406.0K | $196.0K | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$13.0K | -$48.0K | $578.0K | -$415.0K | -$50.0K | $0.00 |
| Research And Development Expense | $39.6M | $141.1M | $107.3M | $19.4M | ||
| Restructuring Costs And Asset Impairment Charges | $16.6M | $7.5M | $72.0M | $23.2M | $0.00 | |
| Income Tax Expense Benefit | $0.00 | -$2.1M | $39.0K | $151.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$156.1M | -$225.3M | -$156.8M | -$37.6M | ||
| Non Cash Interest Expense | $791.0K | $962.0K | $1.0M | -$198.0K | $0.00 | |
| Interest Expense | $5.2M | $1.9M | $0.00 | |||
| Finance Lease Impairment Loss | $0.00 | $827.0K | $7.7M | $166.0K | ||
| Impairment Of Long Lived Assets Held For Use | $4.3M | $60.1M | $1.7M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $138.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$13.6M | -$21.4M | -$28.2M | -$23.0M | -$14.9M | -$24.3M | -$67.4M | -$18.7M | -$57.1M | -$56.2M | -$59.0M | -$54.1M | -$43.0M | -$35.3M | -$23.1M | -$7.3M | -$9.2M | -$4.1M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $122.0K | -$314.0K | -$159.0K | -$291.0K | -$5.0K | $44.0K | $231.0K | -$211.0K | -$230.0K | $391.0K | $220.0K | -$31.0K | $124.0K | $43.0K | $30.0K | $17.0K | $3.0K | -$34.0K |
| Operating Income Loss | -$15.0M | -$23.4M | -$30.6M | -$23.6M | -$14.1M | -$24.0M | -$66.7M | -$21.0M | -$58.4M | -$56.6M | -$58.7M | -$54.3M | -$43.0M | -$35.4M | -$23.4M | -$7.7M | -$4.6M | -$3.9M |
| Operating Expenses | $15.0M | $23.4M | $30.6M | $23.6M | $14.1M | $24.0M | $66.7M | $21.0M | $58.4M | $56.6M | $58.7M | $54.3M | $43.0M | $35.4M | $23.4M | $7.8M | $4.6M | $3.9M |
| Nonoperating Income Expense | -$118.0K | $342.0K | $43.0K | -$530.0K | -$702.0K | -$428.0K | -$1.0M | $628.0K | -$57.0K | -$415.0K | -$1.0M | -$416.0K | -$661.0K | -$104.0K | $71.0K | $449.0K | -$4.6M | -$226.0K |
| General And Administrative Expense | $5.9M | $6.2M | $9.1M | $10.7M | $10.7M | $12.4M | $11.9M | $11.5M | $13.2M | $17.0M | $17.2M | $15.1M | $14.0M | $14.2M | $9.0M | $2.9M | $2.4M | $1.9M |
| Comprehensive Income Net Of Tax | -$13.4M | -$21.7M | -$28.4M | -$22.9M | -$15.0M | -$24.5M | -$67.2M | -$19.1M | -$57.0M | -$56.0M | -$59.1M | -$54.5M | -$42.9M | -$35.3M | -$23.1M | -$7.2M | -$9.2M | -$4.1M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $193.0K | -$354.0K | -$223.0K | $107.0K | -$64.0K | -$215.0K | $270.0K | -$389.0K | $87.0K | $222.0K | -$116.0K | -$354.0K | $106.0K | $30.0K | ||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $71.0K | -$40.0K | -$64.0K | $398.0K | -$59.0K | -$259.0K | $39.0K | -$178.0K | $317.0K | -$169.0K | -$336.0K | -$323.0K | -$18.0K | $0.00 | $0.00 | $0.00 | ||
| Research And Development Expense | $2.9M | $7.3M | $8.5M | $8.5M | $20.7M | $39.7M | $41.5M | $39.2M | $29.1M | $21.2M | $14.4M | $4.9M | $2.2M | $2.0M | ||||
| Restructuring Costs And Asset Impairment Charges | $0.00 | $540.0K | $16.1M | $2.4M | $508.0K | $4.3M | $46.3M | $1.0M | $24.6M | $0.00 | $0.00 | $0.00 | ||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$371.0K | -$609.0K | -$488.0K | -$658.0K | -$159.0K | -$204.0K | $0.00 | $0.00 | $0.00 | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$67.4M | -$18.7M | -$57.1M | -$56.6M | -$59.6M | -$54.6M | -$43.7M | -$35.5M | -$23.3M | -$7.3M | -$9.2M | -$4.1M | ||||||
| Non Cash Interest Expense | $212.0K | $252.0K | $255.0K | $0.00 | ||||||||||||||
| Interest Expense | $2.0M | $2.0M | $590.0K | $636.0K | $807.0K | $331.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Finance Lease Impairment Loss | $0.00 | $187.0K | $7.8M | $0.00 | ||||||||||||||
| Impairment Of Long Lived Assets Held For Use | $16.6M | $2.5M | $13.1M | $0.00 | ||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $52.0K | $42.0K | $44.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $113.9M | $169.4M | $225.8M | $363.6M | $555.2M | -$39.6M | -$6.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.8M | $10.6M | $10.7M | $43.7M | $38.1M | $241.8M | $8.9M |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -$948.0K | -$3.9M | -$3.4M | -$2.9M | $294.0K | $928.0K | |
| Retained Earnings Accumulated Deficit | -$726.5M | -$655.1M | -$581.0M | -$424.9M | -$201.7M | -$44.9M | |
| Property Plant And Equipment Net | $126.0K | $129.4M | $138.7M | $196.9M | $122.0M | $55.3M | |
| Prepaid Expense And Other Assets Current | $3.0M | $9.3M | $8.9M | $8.5M | $9.9M | $4.4M | |
| Other Liabilities Noncurrent | $8.0K | $83.0K | $80.0K | $332.0K | $20.0K | $0.00 | |
| Other Assets Noncurrent | $4.1M | $4.5M | $639.0K | $3.4M | $8.1M | $1.7M | |
| Liabilities Current | $4.8M | $7.9M | $10.6M | $32.8M | $41.4M | $13.3M | |
| Liabilities And Stockholders Equity | $203.5M | $263.6M | $325.6M | $482.1M | $610.0M | $319.0M | |
| Liabilities | $89.7M | $94.1M | $99.8M | $118.5M | $54.8M | $26.6M | |
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$3.9M | $33.0K | -$32.8M | $6.3M | -$203.4M | $232.3M | |
| Cash And Cash Equivalents At Carrying Value | $6.6M | $8.8M | $9.2M | $43.7M | $37.6M | $241.7M | |
| Business Combination Contingent Consideration Liability Noncurrent | $0.00 | $948.0K | $4.9M | $7.9M | $11.0M | $10.9M | |
| Assets Current | $191.4M | $124.5M | $160.8M | $269.4M | $464.0M | $246.1M | |
| Assets | $203.5M | $263.6M | $325.6M | $482.1M | $610.0M | $319.0M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$583.0K | -$228.0K | -$348.0K | -$493.0K | -$87.0K | -$283.0K | |
| Accrued Liabilities And Other Liabilities Current | $4.1M | $7.2M | $9.3M | $30.1M | $34.4M | $8.4M | |
| Accounts Payable Current | $779.0K | $659.0K | $1.2M | $2.4M | $5.6M | $3.5M | |
| Long Term Loans Payable | $84.8M | $84.2M | $81.4M | $72.4M | $0.00 | ||
| Operating Lease Right Of Use Asset | $238.0K | $934.0K | $2.4M | $12.5M | $0.00 | ||
| Operating Lease Liability Noncurrent | $0.00 | $1.0M | $2.9M | $5.2M | $0.00 | ||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $332.0M | $14.9M | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Business Combination Contingent Consideration Liability Current | $0.00 | $360.0K | $1.3M | $1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $120.4M | $131.7M | $144.9M | $176.3M | $195.0M | $205.8M | $234.0M | $296.5M | $311.2M | $410.6M | $458.3M | $508.6M | $601.4M | $635.5M | $665.2M | -$22.8M | -$16.0M | -$7.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.1M | $7.8M | $16.3M | $6.7M | $6.8M | $5.5M | $10.1M | $22.9M | $28.0M | $41.6M | $43.0M | $62.0M | $20.9M | $566.8M | $609.7M | $170.7M | $181.8M | $5.6M |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | $97.0K | -$236.0K | -$346.0K | $220.0K | $0.00 | ||||||||||||
| Retained Earnings Accumulated Deficit | -$718.3M | -$704.7M | -$683.3M | -$643.2M | -$620.2M | -$605.3M | -$568.1M | -$500.6M | -$482.0M | -$371.1M | -$314.8M | -$255.8M | -$146.4M | -$103.4M | -$68.1M | |||
| Property Plant And Equipment Net | $138.0K | $150.0K | $162.0K | $130.1M | $133.1M | $133.9M | $139.4M | $181.5M | $180.0M | $185.1M | $167.1M | $140.8M | $103.7M | $78.6M | $62.9M | |||
| Prepaid Expense And Other Assets Current | $4.2M | $3.3M | $2.6M | $11.6M | $6.3M | $6.3M | $10.6M | $12.5M | $9.3M | $10.4M | $13.1M | $11.2M | $7.7M | $7.7M | $4.1M | |||
| Other Liabilities Noncurrent | $88.0K | $90.0K | $85.0K | $8.0K | $8.0K | $43.0K | $115.0K | $162.0K | $196.0K | $375.0K | $345.0K | $20.0K | $1.5M | $1.1M | $306.0K | |||
| Other Assets Noncurrent | $4.1M | $11.2M | $10.1M | $6.2M | $581.0K | $1.8M | $2.5M | $3.1M | $3.6M | $5.0M | $4.3M | $3.1M | $4.8M | $3.8M | $3.7M | |||
| Liabilities Current | $5.7M | $13.9M | $7.2M | $10.3M | $10.3M | $11.4M | $13.5M | $18.4M | $26.7M | $42.1M | $43.2M | $36.8M | $32.1M | $23.8M | $17.3M | |||
| Liabilities And Stockholders Equity | $211.8M | $231.0M | $237.4M | $272.6M | $294.3M | $306.3M | $340.3M | $408.3M | $427.2M | $532.7M | $568.5M | $564.9M | $647.4M | $672.7M | $696.1M | |||
| Liabilities | $91.3M | $99.3M | $92.5M | $96.2M | $99.3M | $100.5M | $106.2M | $111.8M | $116.0M | $122.2M | $110.2M | $56.4M | $46.0M | $37.2M | $31.0M | |||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $5.6M | -$5.1M | -$15.7M | $23.2M | $367.8M | -$3.6M | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | $5.8M | $7.7M | $15.4M | $6.7M | $6.8M | $5.5M | $9.1M | $21.8M | $27.4M | $41.1M | $42.5M | $61.5M | $20.4M | $566.7M | $609.6M | |||
| Business Combination Contingent Consideration Liability Noncurrent | $948.0K | $948.0K | $948.0K | $2.4M | $5.1M | $5.0M | $8.2M | $8.0M | $7.9M | $10.5M | $10.4M | $11.1M | $10.9M | $10.1M | $11.1M | |||
| Assets Current | $196.3M | $207.4M | $219.3M | $132.6M | $154.9M | $161.0M | $195.6M | $220.6M | $240.1M | $313.7M | $367.7M | $390.7M | $523.1M | $574.5M | $613.8M | |||
| Assets | $211.8M | $231.0M | $237.4M | $272.6M | $294.3M | $306.3M | $340.3M | $408.3M | $427.2M | $532.7M | $568.5M | $564.9M | $647.4M | $672.7M | $696.1M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$612.0K | -$805.0K | -$451.0K | -$520.0K | -$627.0K | -$563.0K | -$525.0K | -$795.0K | -$406.0K | -$335.0K | -$557.0K | -$441.0K | -$104.0K | -$210.0K | -$253.0K | |||
| Accrued Liabilities And Other Liabilities Current | $4.8M | $13.3M | $6.9M | $9.1M | $9.1M | $10.1M | $11.8M | $16.1M | $25.2M | $36.4M | $37.2M | $28.2M | $25.3M | $16.5M | $12.2M | |||
| Accounts Payable Current | $928.0K | $523.0K | $286.0K | $1.2M | $1.2M | $1.2M | $1.6M | $2.2M | $1.3M | $5.3M | $5.8M | $7.7M | $5.3M | $5.2M | $3.7M | |||
| Long Term Loans Payable | $84.6M | $84.4M | $84.2M | $82.2M | $81.9M | $81.7M | $81.2M | $81.5M | $77.1M | $63.0M | $49.1M | |||||||
| Operating Lease Right Of Use Asset | $415.0K | $590.0K | $763.0K | $1.1M | $1.7M | $1.9M | $2.7M | $3.2M | $3.4M | $13.2M | $13.7M | $14.5M | ||||||
| Operating Lease Liability Noncurrent | $0.00 | $6.0K | $48.0K | $1.4M | $2.0M | $2.5M | $3.3M | $3.7M | $4.2M | $5.6M | $6.0M | $6.5M | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $14.9M | ||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Business Combination Contingent Consideration Liability Current | $0.00 | $120.0K | $123.0K | $412.0K | $252.0K | $867.0K | $1.5M | $2.1M | $1.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $8.7M | $17.3M | $18.2M | $30.4M | $26.2M | $1.7M |
| Net Cash Provided By Used In Operating Activities | -$36.6M | -$55.7M | -$82.0M | -$180.2M | -$122.1M | -$29.6M |
| Net Cash Provided By Used In Investing Activities | $25.5M | $54.0M | $41.1M | $114.5M | -$474.4M | -$51.1M |
| Net Cash Provided By Used In Financing Activities | $7.3M | $1.8M | $8.1M | $71.9M | $393.2M | $313.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$6.1M | $221.0K | $241.0K | $430.0K | $5.0M | $898.0K |
| Increase Decrease In Other Noncurrent Assets | -$425.0K | $4.4M | -$1.5M | -$354.0K | $6.5M | $1.1M |
| Increase Decrease In Accrued Liabilities And Other Liabilities | -$2.3M | -$1.9M | -$7.8M | -$14.4M | $12.0M | $4.6M |
| Increase Decrease In Accounts Payable | $116.0K | -$556.0K | -$1.1M | -$1.8M | $3.9M | -$1.1M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $20.0K | -$94.0K | -$201.0K | -$637.0K | -$304.0K | $559.0K |
| Depreciation Depletion And Amortization | $534.0K | $3.6M | $4.8M | $6.0M | $2.8M | $256.0K |
| Proceeds From Stock Options Exercised | $853.0K | $365.0K | $0.00 | $1.5M | $1.8M | $365.0K |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $135.9M | $198.1M | $361.7M | $865.4M | $691.0M | $0.00 |
| Payments To Acquire Property Plant And Equipment | $0.00 | $20.7M | $84.6M | $57.8M | $50.8M | |
| Payments To Acquire Available For Sale Securities Debt | $100.9M | $134.0M | $301.5M | $665.0M | $1.11B | $0.00 |
| Increase Decrease In Operating Lease Liability | -$1.4M | -$1.4M | -$1.4M | -$335.0K | $0.00 | |
| Proceeds From Notes Payable | $0.00 | $85.6M | $0.00 | $70.3M | $0.00 | |
| Stock Issued During Period Value Share Based Compensation | $365.0K | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $3.5M | $4.5M | $4.5M | $7.5M | $2.8M | $62.0K | ||||
| Net Cash Provided By Used In Operating Activities | -$4.2M | -$14.4M | -$34.7M | -$55.1M | -$17.7M | -$2.3M | ||||
| Net Cash Provided By Used In Investing Activities | $9.6M | $9.2M | $14.5M | $77.9M | -$9.1M | -$1.3M | ||||
| Net Cash Provided By Used In Financing Activities | $232.0K | $0.00 | $4.5M | $338.0K | $394.7M | $0.00 | ||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$6.5M | -$1.3M | $773.0K | $2.8M | -$836.0K | -$1.9M | ||||
| Increase Decrease In Other Noncurrent Assets | $1.3M | $197.0K | -$67.0K | $291.0K | $2.2M | $8.0K | ||||
| Increase Decrease In Accrued Liabilities And Other Liabilities | -$1.0M | $858.0K | -$1.5M | -$2.9M | $3.6M | $264.0K | ||||
| Increase Decrease In Accounts Payable | -$376.0K | $20.0K | -$980.0K | -$3.2M | -$271.0K | -$598.0K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $43.0K | -$63.0K | -$24.0K | $729.0K | $78.0K | $268.0K | ||||
| Depreciation Depletion And Amortization | $498.0K | $993.0K | $1.8M | $899.0K | $439.0K | $7.0K | ||||
| Proceeds From Stock Options Exercised | $404.0K | $0.00 | $0.00 | $338.0K | $1.4M | $0.00 | ||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $47.4M | $59.9M | $105.0M | $350.5M | $0.00 | |||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $8.5M | $20.2M | $9.1M | $968.0K | |||||
| Payments To Acquire Available For Sale Securities Debt | $38.2M | $50.7M | $82.0M | $252.4M | $0.00 | |||||
| Increase Decrease In Operating Lease Liability | -$163.0K | -$200.0K | -$446.0K | -$456.0K | ||||||
| Proceeds From Notes Payable | $0.00 | $4.5M | $0.00 | |||||||
| Stock Issued During Period Value Share Based Compensation | $71.0K | $404.0K | $159.0K | $269.0K | $565.0K | $338.0K | $1.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 6.7M | 6.5M | 6.5M | 6.5M | 106.0M | 16.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 6.7M | 6.5M | 6.5M | 6.5M | 106.0M | 16.0M | |
| Earnings Per Share Diluted | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | |
| Earnings Per Share Basic | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 111.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 6.8M | 6.5M | 6.5M | 6.5M | 129.0M | 20.6M | |
| Common Stock Shares Issued | 6.8M | 6.5M | 6.5M | 6.5M | 129.0M | 20.6M | |
| Temporary Equity Shares Outstanding | 0.00 | 70.2M | 15.0M | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 6.8M | 6.6M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 129.7M | 129.4M | 129.1M | 128.8M | 128.7M | 35.0M | 16.9M | 16.8M | 13.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 6.8M | 6.6M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 129.7M | 129.4M | 129.1M | 128.8M | 128.7M | 35.0M | 16.9M | 16.8M | 13.0M | |
| Earnings Per Share Diluted | $-2.01 | $-3.24 | $-4.32 | $-3.54 | $-2.29 | $-3.74 | $-10.37 | $-2.87 | $-8.77 | $-0.43 | $-0.46 | $-0.42 | $-0.33 | $-0.27 | $-0.66 | $-0.43 | $-0.55 | $-0.31 | |
| Earnings Per Share Basic | $-2.01 | $-3.24 | $-4.32 | $-3.54 | $-2.29 | $-3.74 | $-10.37 | $-2.87 | $-8.77 | $-0.43 | $-0.46 | $-0.42 | $-0.33 | $-0.27 | $-0.66 | $-0.43 | $-0.55 | $-0.31 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 6.8M | 6.8M | 6.6M | 6.5M | 6.5M | 6.5M | 130.1M | 130.1M | 130.1M | 129.8M | 129.6M | 129.2M | 128.9M | 128.7M | 128.7M | ||||
| Common Stock Shares Issued | 6.8M | 6.8M | 6.6M | 6.5M | 6.5M | 6.5M | 130.1M | 130.1M | 130.1M | 129.8M | 129.6M | 129.2M | 128.9M | 128.7M | 128.7M | ||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 59.6M | 59.6M | 15.0M | |||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.7M | $17.3M | $18.2M | $30.4M | $26.2M | $1.7M |
| Interest Income Other | $3.9M | $7.0M | $8.9M | $3.7M | $80.0K | |
| Foreign Currency Transaction Gain Loss Before Tax | $484.0K | -$275.0K | $680.0K | -$1.4M | -$710.0K | $643.0K |
| Additional Paid In Capital | $840.9M | $824.8M | $807.2M | $789.0M | $757.0M | $5.6M |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $12.4M | $15.1M | $2.9M | ||
| Interest Paid Net | $5.0M | $8.0M | $6.6M | $1.1M | $0.00 | |
| Unrealized Gain Loss On Derivatives | $0.00 | -$1.1M | -$1.1M | $1.4M | $0.00 | |
| Accretion On Invested Securities | $37.0K | $4.3M | $6.8M | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.8M | $1.8M | $3.5M | $4.1M | $4.2M | $4.5M | $4.7M | $4.4M | $4.5M | $8.0M | $8.3M | $7.5M | $8.7M | $5.7M | $2.8M | $331.0K | $899.0K | $62.0K |
| Interest Income Other | $893.0K | $1.0M | $1.2M | $1.7M | $1.9M | $2.1M | $2.3M | $2.3M | $2.1M | $1.3M | $486.0K | $97.0K | $22.0K | $15.0K | ||||
| Foreign Currency Transaction Gain Loss Before Tax | $223.0K | -$163.0K | $373.0K | $454.0K | $24.0K | -$156.0K | ||||||||||||
| Additional Paid In Capital | $839.3M | $837.2M | $828.7M | $820.1M | $815.8M | $811.7M | $802.6M | $797.9M | $793.5M | $782.0M | $773.7M | $764.8M | $747.9M | $739.0M | $733.5M | |||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $9.5M | $10.4M | $862.0K | $0.00 | |||||||||||||
| Interest Paid Net | $886.0K | $1.7M | $1.5M | $0.00 | ||||||||||||||
| Unrealized Gain Loss On Derivatives | $0.00 | -$246.0K | -$369.0K | |||||||||||||||
| Accretion On Invested Securities | $236.0K | $1.1M | $1.3M | $0.00 |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.